Article Text

PDF
GI highlights from the literature
  1. Mairi H McLean, Education Editor

Statistics from Altmetric.com

Basic science

TH9 cells: new players in inflammatory bowel disease

▸ Gerlach K, Hwang Y, Nikolaev A, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol 2014;15:676–86.

T lymphocyte subsets play a critical role in the pathogenesis of IBD, but the relationship between T cell activation and epithelial cell damage in IBD remains to be elucidated. An increase in TH17 cell responses along with a decrease in regulatory T cell responses are associated with UC and Crohn's disease (CD); however, UC patients have a stronger TH2-related immune response, while CD patients have increased levels of TH1-related cytokines. In this study, the authors set out to investigate the role that TH9 cells play in the pathogenesis of IBD by characterising interleukin 9 (IL-9) expression in patients with IBD and in mouse models of acute and chronic colitis. TH9 cells, characterised by production of IL-9 and expression of the transcription factor PU.1, have been shown to contribute to parasitic infection and allergy. PU.1-expressing and IL-9-producing T cells were found in the gut mucosa of mainly UC patients, while cells that were targets of the IL-9 receptor (IL-9R) were located in the intestinal epithelium of UC and CD patients. In a mouse model of colitis induced by oxazolone, IL-9-producing TH9 cells were identified as key promoters of disease. Mice given anti-IL-9 or mice with PU.1 deficiency in T cells had reduced acute colitis. Using a novel IL-9 reporter mouse, the authors identified CD4 T cells as the principle source of IL-9. In oxazolone-induced colitis, IL-9 impaired barrier function and prevented wound healing. Together, this study demonstrates the critical role that IL-9-producing TH9 cells plays in the pathogenesis of IBD, particularly UC, by regulating intestinal barrier integrity and immunological function. From a clinical aspect, targeting IL-9 may be a …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.